Hyperlipidemia Drugs Market Trends 2034: Focus on Cardiovascular Risk Reduction
Hyperlipidemia is one of the most common metabolic disorders worldwide and a major risk factor for cardiovascular diseases, stroke, and peripheral artery disease. The condition is characterized by elevated levels of cholesterol and triglycerides in the bloodstream, necessitating long-term treatment and monitoring. Growing awareness regarding cardiovascular health, increasing screening programs,...
0 Σχόλια 0 Μοιράστηκε 154 Views 0 Προεπισκόπηση
Nguza AI Social Earning Marketplace https://nguza.com